e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
J. R. Badia, M. Cavalcanti, X. Filella, M. Ferrer, I. Aldabo, A. Torres (Barcelona, Spain)
Source:
Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Session:
Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Session type:
Oral Presentation
Number:
135
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. R. Badia, M. Cavalcanti, X. Filella, M. Ferrer, I. Aldabo, A. Torres (Barcelona, Spain). Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP). Eur Respir J 2005; 26: Suppl. 49, 135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Comparison of CPIS (clinical pulmonary infection score) and clinical criteria in the diagnosis of ventilator associated pneumonia in ICU complex patients
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007
D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Pulmonary apoptosis and related markers in ventilator acquired pneumonia (VAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 13s
Year: 2003
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002
Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Impact of host status, bacteria and antibiotic therapy on systemic inflammatory response syndrome (SIRS) development in community-acquired pneumonia (CAP)
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007
Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003
Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept